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The efficacy of five ovulation-synchronization protocols with FTAI in treatment of cows 17 
diagnosed with follicular cysts was investigated in a onrandomized study in a single herd. Cows 18 
identified with follicular structures >25 mm on two subsequent ultrasonographic (USG) 19 
examinations 7 to 10 days apart (n = 552) were assigned to one of the five treatment regimens on 20 
the day of the second USG examination. Treatment regimens were Ovsynch (GnRH-7d-PGF2α-21 
56h-GnRH-16h-FTAI), New-CIDR (as Ovsynch with a new CIDR insert being fitted between 22 
days 0 and 7), Reused-CIDR (as New-CIDR but the CIDR insert was previously used for 7 days 23 
in another cow), G-New CIDR (Pre-GnRH on day 0 with the New-CIDR regimen being initiated 24 
7 days later), and RG-Ovsynch (Pre-GnRH on day 0 and then every 7 days until detection of a 25 
luteal structure upon USG examination; at that point the Ovsynch was initiated). A subset of 26 
cows was subjected to ovarian USG examination at the ime of PGF2α administration, at 27 
insemination, and 8 to10 days post-insemination. Progesterone-releasing ability of new and 28 
reused CIDR inserts were evaluated in cows diagnosed with severe ovarian inactivity (n = 16). 29 
The data were analyzed using logistic regression with pregnancy per AI on days 30 (P/Al 30) and 30 
70 (P/AI 70) post-insemination were included as outc me measures. Compared with Ovsynch, 31 
RG-Ovsynch improved the P/AI 30 (OR = 2.6, P = 0.03) and the P/AI 70 (OR = 2.5, P = 0.05). 32 
New-CIDR and G-New CIDR were associated with non-significant increase in P/AI 30 (OR = 33 
2.1, P = 0.09 and OR = 2.3, P = 0.07, respectively) and P/AI 70 (OR = 2.01, P = 0.09 and OR = 34 
2.2, P = 0.09, respectively). Reused-CIDR was not associated with improvement in P/AI (P = 35 
0.93 and 0.79 for P/AI 30 and P/AI 70, respectively). RG-Ovsynch had a longer diagnosis-to-36 
FTAI interval (median 24, IQR 17,31). The dominant ovarian structures and the presence of a 37 
cyst or a luteal structure at PGF2α administration or at insemination were not associated with 38 
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P/AI. The new and re-used CIDR inserts produced comparable concentrations of serum 39 
progesterone 3 h, 3 days and 7 days post CIDR insertion. In conclusion, the RG-Ovsynch 40 
improved the P/AI whereas the New-CIDR and the G-New CIDR regimens tended to increase 41 
the P/AI compared with Ovsynch. Marginal differences in P/AI between RG-Ovsynch, New-42 
CIDR, and G-New-CIDR together with prolonged diagnosis-to-FTAI in RG-Ovsynch should be 43 
considered if to evaluate the economic value of these r gimens.  44 
Keywords 45 
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1. Introduction 47 
Cystic ovarian disease has negative impacts on the reproductive performance of dairy cattle, 48 
and hence it may decrease the overall productivity of dairy enterprises [1]. In cystic ovarian 49 
disease, the mature follicle continues to grow to larger diameters without ovulation and persists 50 
for a prolonged period [2, 3]. These cows, however, have follicular waves that grow to different 51 
stages followed by regression without ovulation [2, 3]. The diameter at which an ovarian 52 
structure is defined as a follicular cyst varied among literatures from 17 to 25 mm [4-10], and the 53 
reported prevalence of cystic ovarian disease varied f om 10 to 16 % with higher prevalence 54 
being reported around the end of the voluntary waiting period [11]. Cystic ovarian disease is 55 
commonly treated with LH-inducing hormones such as GnRH, LH-like medications such as 56 
human chorionic gonadotrophin (hCG) [9, 12-14], or with intravaginal progesterone-releasing 57 
inserts [15-18]. Cows receiving these treatments are monitored carefully for estrous sings and 58 
inseminated at the first post-treatment estrus. Such treatment regimens, however, have been 59 
associated with prolonged treatment-to-insemination intervals [5, 9, 12, 13, 19, 20] with 60 
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difficulties to differentiate between recovery in response to treatment and spontaneous recovery 61 
[21]. 62 
Because cows with cystic ovarian disease develop follicular waves [2, 3, 17], ovulation-63 
synchronization treatment regimens with fixed-time artificial insemination (FTAI) has been 64 
suggested as a therapeutic intervention for these cows [3, 22, 23]. Ovsynch (GnRH on day 0, 65 
PGF2α on day 7, GnRH on day 9, and insemination on day 10) has been found to perform sub-66 
optimally in anovular cows compared with cyclic cows [7, 24, 25], and therefore, several 67 
modifications to the Ovsynch such as starting the Ovsynch with PGF2α plus GnRH followed by 68 
PGF2α 14 days later [24, 26], replacing the second GnRH dose with hCG [27], or treatment of the 69 
cows with hCG 5 days post-insemination [28] have ben investigated to improve the efficiency 70 
of Ovsynch in anovular cows. The suboptimal performance of the Ovsynch in anovular cows is 71 
thought to occur because the new synchronized follicular wave that emerges after the first GnRH 72 
treatment of the Ovsynch develops and matures under a low progesterone level [25, 29, 30]. To 73 
mitigate this, cows with ovarian cysts have been pre-treated with GnRH 6 to7 days (Pre-GnRH) 74 
before initiating the Ovsynch [31, 32]. Pre-GnRH treatment has been found to improve the 75 
pregnancy per artificial insemination (P/AI) in one study [32], however, another study reported 76 
reduced P/AI following treatment with Pre-GnRH [31]. This controversy could have resulted due 77 
to differences in the response to the pre-GnRH treatm nt between cows. Therefore, we 78 
hypothesised in the current study that the performance of the Ovsynch in cows with ovarian 79 
cystic disease could be improved if the response to the Pre-GnRH treatment is evaluated via 80 
ultrasonographic ovarian examination with the Pre-GnRH dosing being repeated until a luteal 81 
structure is identified before initiating the Ovsynch treatment regimen. 82 
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Another alternative to improve the efficiency of Ovsynch in anovular cows is to incorporate a 83 
controlled internal drug release (CIDR) between days 0 and 7 of the Ovsynch (CIDR-Ovsynch). 84 
Several studies have investigated the efficacy of CIDR-Ovsynch in reproductive management of 85 
dairy cows, but a limited number of studies have investigated its efficiency in cows with 86 
follicular cysts [10, 20]. Furthermore, most of these studies used a limited number of cows, and 87 
the results obtained were contradictory [4, 10, 33]. In the GnRH-PGF2α based ovulation-88 
synchronization regimen, the progesterone-releasing inserts are usually used for 7 days, however, 89 
the commercially available CIDR is designed to produce an elevated concentration of 90 
progesterone for 14 days [34]. Therefore, reusing the progesterone-releasing inserts has been 91 
investigated to reduce the cost of the reproductive management of dairy cows [35-38]. 92 
Previously used CIDR and Sincrogest inserts have been r ported to induce a lower progesterone 93 
concentration than the new ones in high lactating dairy cows and anestrus buffaloes [35-37]. The 94 
follicular growth and the P/AI in seasonal anestrus b ffaloes, however, were similar after 95 
incorporating new or previously used Sincrogest insets into an estradiol-progesterone based 96 
ovulation-synchronization regimen [37]. To the best of our knowledge, the efficiency of reused 97 
CIDR has not been evaluated in cows with follicular cysts. Therefore, the objectives of the 98 
current study were (i) to investigate the efficiency of some modifications to the Ovsynch (mainly 99 
repeated pretreatment with GnRH until detection of a luteal structure or CIDR insertion) in 100 
treatment of cows diagnosed with follicular cysts and (ii) to compare the progesterone-releasing 101 
ability and treatment efficacy of new and reused CIDR inserts.  102 
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2. Materials and methods  103 
2.1. Herd and animals  104 
A prospective study was conducted over a 2-year period in a commercial dairy herd of 105 
approximately 1,300 dairy cows that is located in the outskirts of Cairo, Egypt. The herd 106 
contained Holstein, Brown Swiss, and crossbred cows (Holstein × Brown Swiss and Holstein × 107 
Fleckvieh) that were housed in shaded free stalls fitted with fans and water sprinklers. The 108 
nutritional requirements of the cows were determined according to the National Research 109 
Council nutritional guidelines [39]. Cows were fed a total mixed ration consisted mostly of corn 110 
silage, citrus silage, corn, and soybean. Cows weremilked three times daily and were vaccinated 111 
against bovine viral diarrhea, infectious bovine rhinotracheitis, foot and mouth disease, 112 
ephemeral fever, lumpy skin disease, rift valley fever, and clostridial diseases. Cows were 113 
equipped with a pedometer system to record their walking activity, and this was employed as the 114 
main estrus detection method. The routine reproductive management program of the herd 115 
included a weekly examination of all open cows beginning at 45 days in milk (DIM), with a 116 
voluntary waiting period set at 60 days. A commercial farm management software (AfiFarm 117 
version 4.1, Afimilk Ltd, Kibbutz Afikim,1514800, Israel) was used to record all reproductive 118 
data. The study was approved by the Institutional Animal Care and Use Committee, Zagazig 119 
University, Egypt (ZU-IACUC). 120 
2.2. Case definition 121 
Cows potentially suffering from follicular cysts were identified during ultrasonographic 122 
(USG) examination of open cows at 45 to 50 DIM or du ing pregnancy diagnosis on day 30 to 32 123 
post-insemination. These were defined as cows that had a thin-walled follicular structure >25 124 
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mm without a luteal structure. Potentially affected cows were re-examined 7 to 10 days later, and 125 
the diagnosis of the follicular cyst was confirmed if a luteal structure could not be visualized and 126 
the cystic structure was still present [40]. All examinations were performed using an IMAGO 127 
ultrasound unit (IMV imaging UK, Ltd, Bellshill, Scotland, ML4 3NJ) supplied with a 7.5–10 128 
MHz rectal probe.  129 
2.3. Treatment regimens 130 
On each visit to the farm, all cows diagnosed with follicular cysts were immediately treated 131 
using one of five ovulation-synchronization treatment regimens, namely Ovsych, New-CIDR, 132 
Reused-CIDR, G-Reused-CIDR and RG-Ovsynch. Cows in wh ch the Ovsynch treatment 133 
regimen was used (n = 38) were treated with GnRH (100 µg gonadorelin acetate im; Ovurelin, 134 
Bayer, New Zealand) on day 0, PGF2α (500 mg cloprostenol im; Ovuprost, Bayer, New Zealand) 135 
on day 7, a second dose of GnRH 56 hours after the PGF2α treatment, and inseminated 16 h later. 136 
The New-CIDR treatment regimen (n = 261) was similar to the Ovsynch treatment regimen, but 137 
with a new intravaginal CIDR insert containing 1.38 g of progesterone (Eazi-Breed CIDR; 138 
Zoetis, NJ, USA) being inserted between days 0 and 7. Cows treated with the Reused-CIDR 139 
treatment regimen (n = 63) received the same treatments described in the Ovsynch treatment 140 
regimen, but with a reused CIDR insert being fitted b tween days 0 and 7. The reused-CIDR 141 
insert was previously used once for 7 days in a different cow and was cleaned by an antiseptic 142 
solution before reusing. The G-New CIDR treatment rgimen (n = 161) involved treatment of 143 
cows with a single dose of Pre-GnRH 7 days before initiating the New-CIDR treatment regimen. 144 
The RG-Ovsynch treatment regimen (n = 141) involved pretreatment of cows with Pre-GnRH on 145 
day 0 followed by USG examination 7 days later. Identification of a luteal structure upon USG 146 
examination indicated a successful response to Pre-GnRH treatment, and the Ovsynch treatment 147 
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regimen was initiated. If a luteal structure could not be identified, a second dose of Pre-GnRH 148 
treatment was administered, and the cows were examined again 7 days later. This procedure was 149 
repeated every 7 days until a luteal structure was identified before initiating the Ovsynch 150 
treatment regimen. The luteal structure identified was either a corpus luteum (CL) with 151 
regression of the cyst, a luteinized cyst, or a CL in the presence of the cyst. Assignment of cows 152 
to these treatments was nonrandomized.  A graphical illustration of the treatment regimens is 153 
shown in Fig. 1.  154 
Cows in all treatments received FTAI performed by a tot l of 12 inseminators using semen 155 
doses from 30 bulls. Cows that did not return to esrus underwent a per rectum USG pregnancy 156 
diagnosis 30 to 32 days post-insemination. Pregnant cows underwent a second USG examination 157 
approximately 70 days post-insemination and their pregnancy status was noted. The P/AI 30 and 158 
P/AI 70 were calculated as the proportion of cows out of all treated cows that were diagnosed as 159 
pregnant on day 30 or 70 post-insemination, respectively. Cows were defined as recovered from 160 
the cystic ovarian disease if they were returned into estrus 17 to 29 days post insemination, were 161 
diagnosed as pregnant 30 to 32 days post-insemination or were not identified with a follicular 162 
cyst on pregnancy diagnosis examination in the caseof n gative pregnancy scan.  163 
2.4. Data collection  164 
Additional information recorded included the date of insemination, breed, age, parity, DIM, 165 
number of inseminations and 305-day milk yield. The daily ambient temperature and humidity 166 
information were collected from a local weather station located at the Cairo airport; about 10 km 167 
to the west of the farm. The monthly mean temperature-h midity index (THI) was calculated 168 
from the temperature and humidity data as follows: THI= (1.8 × AT + 32) - ((0.55 - 0.0055 × 169 
RH) x (1.8 × AT - 26)) [41]; where AT refers to the ambient temperature and RH is the relative 170 
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humidity. THI was measured on the day of insemination and the monthly mean of THI was 171 
calculated. The mean monthly value was included in the analysis as a categorical variable where 172 
the calendar year was split according to the monthly THI into 4 periods; THI < 65, 65 ≤ THI < 173 
70, 70 ≤ THI <75 and THI ≥ 75.  174 
2.5. Ultrasonographic examinations  175 
On day 0, cows in all treatment regimens had a follicular cyst that persisted for at least 7 to 176 
10 days. To monitor the disappearance of the follicular cyst and the development of a luteal 177 
structure during and after the end of the treatment r gimens, a subgroup of cows in the New-178 
CIDR, Reused-CIDR, G-New CIDR and RG-Ovsynch treatment regimens were subjected to 179 
USG examinations on the day of PGF2α administration, on the day of insemination, and 8 to10 180 
days post-insemination. Because of limited time and resources, not all cows were examined on 181 
every examination time point. Table 1 provides a summary of findings that were considered on 182 
each examination time point. During each examinatio, signs of ovulation (development of a CL 183 
that was not present on the previous examination), and changes in the USG appearance of the 184 
follicular cyst such as the development of a luteinized thick wall around the follicular cyst 185 
(luteinization) or the disappearance of the follicuar cyst were recorded. According to the ovarian 186 
structures identified on each examination, cows were classified as either having a follicular cyst 187 
(a thin-walled follicular cyst without a luteal tissue), a follicle (a follicular structure without a 188 
follicular cyst   or a luteal structure), a CL (a CL without a follicular cyst), a CL plus a follicular 189 
cyst (both a thin-walled follicular cyst and a CL), or a luteal cyst (a cyst with >3 mm wall 190 
thickness). To investigate the association between th  development of a luteal structure and P/AI, 191 
cows identified with a CL, a luteal cyst, or a CL plus a follicular cyst were grouped together and 192 
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classified as having a luteal structure.  Similarly, cows identified with a follicular cyst or a CL 193 
plus a follicular cyst were grouped and classified as having a follicular cyst. 194 
2.6. Evaluation of the progesterone-releasing ability of new and reused CIDR  195 
Sixteen Holstein cows that were diagnosed with severe ovarian inactivity were randomly 196 
fitted with new or reused CIDR inserts for 7 days. Severe ovarian inactivity was characterized by 197 
the absence of a CL and ovarian follicles >8 mm during 3 subsequent USG examinations at 7 198 
days intervals before the experiment. These findings were also confirmed by USG examination 199 
on each of the blood sampling occasions and 7 days after removing the CIDR inserts. These 200 
cows were used to assure the absence of an ovarian source of progesterone. Venous blood 201 
samples were collected at the time of CIDR insertion, and 3 h, 3 days, and 7 days post CIDR 202 
insertion. Blood samples were transported in an icebox to the laboratory where they were 203 
centrifuged at 3000 g for 10 minutes, and sera were ha vested and stored at –20 oC until testing. 204 
Progesterone concentration in serum samples was meaured using an electrochemiluminescence 205 
immunoassay “ECLIA” kit on an Elecsys immunoassay analyzer (Elecsys, Roche Diagnostic 206 
Gmbh, Mannheim, Germany). The test has a measurement range of 0.05 to 60 ng/ml and 207 
functional sensitivity (limit of quantification) of 0.15 ng/ml. The coefficient of variation of 208 
reference samples at a concentration of 0.659 and 3.03 ng/ml were 5.2 and 3.0, respectively.  209 
2.7.  Statistical analyses  210 
The P/AI 30 and P/AI 70 were the primary outcomes of interest in all analyses. The 211 
prevalence of a positive pregnancy within each level of categorical variables together with 95% 212 
confidence intervals were reported. The summary statistics (median and interquartile range 213 
[IQR]) of continuous variables in cows identified with a positive or a negative pregnancy were 214 
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also calculated (Supplementary Tables 1 and 2). Univariable logistic regression was performed 215 
to investigate the association between explanatory variables including the treatment regimens, 216 
and each of the outcome variables. The linearity of the relationship between continuous 217 
explanatory variables and the log odds of a positive pregnancy scan was investigated using 218 
generalized additive models (GAMs) [42]. Continuous variables were then fitted as linear terms 219 
in logistic regression analyses or categorized based on the results of the GAMs. The cut-off 220 
points used were informed by plotting the GAMs results. The variable DIM was categorized into 221 
<200, 200–40, and >400 days for the P/AI 30 outcome but included as a linear fit in the model 222 
investigated risk factors for P/AI 70. Cows were classified as primiparous (first lactation) or 223 
multiparous (second or more lactations). The likelihood ratio test (LRT) P value was calculated 224 
for each of the explanatory variables by comparing the null logistic regression model and the 225 
model containing the variable. 226 
Variables identified with an LRT P value <0.25 were used to build multivariable logistic 227 
regression models. The multivariable models were built using a forward selection approach in 228 
which variables were added in succession into the models. The improvement in model fit was 229 
justified if the added variable resulted in an LRT P value of <0.05 and/or a reduction in AIC by 230 
at least 2 when nested models were compared. Excluded variables were forced back into the 231 
model to make sure no confounding or important variables have been excluded. Interaction 232 
between variables retained in the final model were evaluated for statistical significance. The 233 
model fit was then evaluated using the Hosmer-Lemeshow goodness-of-fit test and influential 234 
observations were investigated by calculating and plotting delta betas. In final models, the 235 
random effects of cow, bull, and inseminator were evaluated by comparing the model with and 236 
without the random effect using the LRT. The amount of variability in the log odds of positive 237 
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pregnancy attributed to each of the random effects was calculated using the latent-variable 238 
approach. The method assumes the binary outcome arises f om an underlying continuous 239 
distribution and that the level one (individual pregnancies) variance on the logit scale is π2/3  240 
The relationships between the dominant ovarian structu es identified on each of the 241 
examination occasions and the log odds of P/AI 30 and were examined using logistic regression 242 
models following adjustment for the treatment regimen and the THI. Furthermore, the proportion 243 
of ovarian structures identified during examination were compared between treatment regimens 244 
using a chi-square test. Fishers’ exact test was used if one or more of the cells in the contingency 245 
table contained an expected frequency of <5 observations. The progesterone concentration was 246 
compared between cows treated with reused or new CIDR inserts using a random intercept linear 247 
mixed-effects model. The model takes into account the dependent nature of the data where 248 
progesterone concentration was measured within the same cows over time through 249 
including the time and the type of CIDR (both were categorical variables) as fixed effects 250 
variables and ‘cow’ as a random effect. Post-hoc comparisons of least square means were 251 
performed using the Tukey’s post-hoc test. All analyses were performed using R software 252 
version 3.5.3 [43] and the critical probability was set at P <0.05 for all analyses. 253 
3. Results  254 
3.1. Factors affecting the odds of pregnancy 255 
Follicular cyst was diagnosed on 664 occasions in 522 cows during the study period. Of the 256 
cows that had repeated treatments (n = 116), 65 cows were treated in the same lactation and 51 257 
cows were treated in different lactations. At the time of insemination, cows had a median age of 258 
49.8 months (IQR 37.1, 65.8), a median parity of 2 (IQR 1, 3), a median DIM of 136.5 days 259 
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(IQR 86, 261), and a median insemination number of 2 (IQR 1,4). The cows had a median actual 260 
305-day milk yield of 9905 kg (IQR 8741, 11119).  261 
Cows expressed estrus sings 17 to 29 days post insemi ation, diagnosed as pregnant 30 to 32 262 
days post-insemination, or diagnosed as non-pregnant, but with the absence of a follicular cyst 263 
were defined as recovered from the cystic ovarian dsease. The overall recovery rate within 30 264 
days of the end of the treatment regimens was 89.8%, and it did not differ significantly between 265 
treatment regimens (X2 = 1.42, P = 0.84). The total percentage of P/AI 30 and P/AI 70 were 266 
32.2% (n = 214) and 28.2% (n = 187), respectively. Pregnancy loss between gestational days 30 267 
and 70 was 12.7% (n = 27). The proportion of cows with pregnancy loss did not differ between 268 
treatment regimens (P = 0.68). Of note that, the P/AI 30, P/AI 70, and pregnancy loss in cows 269 
that were inseminated in standing estrus with a normal inter-estrus interval (i.e. 17 to 25 days) in 270 
the same herd during the study period were 31.6% (797/2523), 27.9% (705/2523) and 11.5% 271 
(92/797), respectively. 272 
Results of univariable analyses of variables associated with the log odds of P/AI 30 and P/AI 273 
70 are presented in supplementary Tables 1 and 2, respectively. The results of the final 274 
multivariable models are presented in Table 2. Cows inseminated when the THI was >70 showed 275 
lower P/AI 30 and P/AI 70 than those inseminated when THI was <65. Cows treated with the 276 
RG-Ovsynch treatment regimen showed higher P/AI 30 (P = 0.03) and P/AI 70 (P = 0.05) 277 
compared with those treated with the Ovsynch treatmn  regimen. Cows treated with the New-278 
CIDR and the G-New CIDR treatment regimens showed non-significant improvement in P/AI 30 279 
(P = 0.09 and 0.07, respectively) and P/AI 70 (P = 0.09). The differences in the odds of 280 
pregnancy in cows treated with RG-Ovsynch, New-CIDR, and G-New CIDR treatment regimens 281 
were marginal and did not reach statistical significance. There was no interaction between the 282 
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treatment regimens and the THI on the P/AI. The liklihood ratio test P values of the random 283 
effect of the cow in the final P/AI 30 and P/AI 70 multivariable models were 0.08 and 0.06, 284 
respectively. The intra-class correlation coefficients for the cow random effect were 26% and 285 
32% for the two models, respectively. Neither the random effect of bull nor that of the 286 
inseminator explained any variation in the log odds of the P/AI 30, or the P/AI 70 in the final 287 
models.  288 
3.2. Dominant ovarian structures at the time PGF2α administration, on day of insemination, and 289 
8–10 days post-insemination and their relation to P/AI  290 
 The intervals between the onset of the treatment regimen and FTAI varied among treatment 291 
regimens. This was 10 days in the Ovsynch, New-CIDR, and Re-used CIDR treatment 292 
regimens,17 days in the G-New CIDR treatment regimen, and 17–52 days (median 24, IQR 293 
17,31) in the RG-Ovsynch treatment regimen. The number of weekly Pre-GnRH treatment 294 
administrations until detection of a luteal structure in cows treated with the RG-Ovsynch 295 
treatment regimen varied from 1 to 6 (median 2, IQR = 1, 3). Of the 141 cows treated with RG-296 
Ovsynch, the proportion of cows that showed a lutea structure after 1, 2, 3, 4, 5, or 6 Pre-GnRH 297 
treatment administrations were 41.2, 25.5, 18.4, 11.4, 2.8, and 0.7 %, respectively. Luteal 298 
structures identified after GnRH pretreatments and t the beginning of the Ovsynch were either a 299 
CL in the presence of the cyst (34.7%, n = 49), a CL with disappearance of the follicular cyst 300 
(53.2%, n = 75), or luteinization of the cyst (12.1%, n = 17). Cows identified with a CL in the 301 
presence of a follicular cyst at the beginning of the Ovsynch in the RG-Ovsynch treatment 302 
regimen tended to have lesser P/AI 30 (P = 0.07) compared with those identified with a CL 303 
without a follicular cyst (Table 3).   304 
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At the time of PGF2α administration, the proportion of cows identified with a luteal structure 305 
was higher in the RG-Ovsynch (97.3%, P < 0.001) compared with the New-CIDR (46.9%) and 306 
the Reused-CIDR (63.1%) treatment regimens. The proporti ns of cows that retained the 307 
follicular cyst until the time of PGF2α administration did not vary among treatment regimens 308 
(Fig. 2A). The dominant ovarian structures, development of a luteal structure, or the presence of 309 
a follicular cyst at the time of PGF2α administration were not associated with P/AI 30 (Table 3). 310 
The proportion of cows that retained the follicular cyst up to the time of insemination were 311 
similar among treatment regimens (Fig. 2B), and this was not associated with P/AI 30 (Table 3).  312 
The proportion of cows ovulated at the end of the treatment regimens (i.e. had a CL or a CL 313 
plus a cyst) did not differ between treatment regimens. Similarly, the proportion of cows that 314 
retained a follicular cyst (i.e. had a follicular cyst or a CL plus a cyst) up to 8 to 10 days post-315 
insemination did not differ among treatment regimens. Only 4.4 to 13.5% of the cows showed a 316 
follicular cyst without a luteal structure on day 8 to 10 post-insemination (Fig. 2C). The P/AI 30 317 
was similar in cows that ovulated after the disapperance of the follicular cyst (i.e. had a CL with 318 
no follicular cyst on day 8 to10 post-insemination) a d those ovulated in the presence of the 319 
follicular cyst (i.e. showed a CL plus a follicular cyst on day 8 to 10 post-insemination) (41.3 vs 320 
30.4%, respectively; Table 3). 321 
3.3. Progesterone concentration in cows treated with newand reused CIDR inserts   322 
The linear mixed-effects model showed that the use of new or reused CIDR inserts was not 323 
associated with significant differences in blood progesterone concentrations at all sampling 324 
occasions (P = 0.1). The mean ± standard deviation baseline serum progesterone concentrations 325 
in cows received new or reused CIDR inserts were 0.60 ± 0.08 and 0.47 ± 0.19, respectively. By 326 
3 h after CIDR insertion, the mean serum concentration of progesterone increased (P <0.001) to 327 
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1.96 ± 0.15 and 1.49 ± 0.86 ng/ml in cows received n w and reused CIDR inserts, respectively. 328 
The serum progesterone concentration 3 days post CIDR insertion was comparable to that 329 
measured 3 h after CIDR insertion in cows received n w or reused CIDR inserts. On day 7 post 330 
CIDR insertion, the serum progesterone concentration significantly decreased compared with the 331 
concentration on day 3 but remained significantly higher than the baseline concentration in both 332 
groups (Fig. 3).  333 
4.  Discussion  334 
The present study investigated the efficacy of some modifications to the Ovsynch in the 335 
treatment of cows diagnosed with follicular cysts. These included either inclusion of a new or a 336 
previously used CIDR inserts or pretreatment with GnRH until detection of a CL before 337 
initiating the Ovsynch. Repeated administration of Pre-GnRH treatments until the development 338 
of a luteal structure before initiating the Ovsynch (RG-Ovsynch) significantly improved the P/AI 339 
30 and P/AI 70 compared with the Ovsynch treatment r gimen. There was also a trend toward 340 
improved P/AI 30 and P/AI 70 in cows treated with New-CIDR and G-New CIDR treatment 341 
regimens.  342 
The low P/AI 30 (21.1%) observed in the current study after imposing the Ovsynch treatment 343 
regimen agrees with previous reports [5-7, 27, 32].Two previous studies [10, 44],however, 344 
reported high P/AI (41 to 46.5%) following treatment with Ovsynch. These two studies used a 345 
small number of cows with cystic ovarian disease (n = 15 to 17), and this high P/AI was likely to 346 
be a chance finding. In the current study, the use of RG-Ovsynch treatment regimen improved 347 
the P/AI compared with the Ovsynch regimen. Pretreatm nt with a single dose of Pre-GnRH 348 
before starting the Ovsynch improved the P/AI in cows with cystic ovarian disease in one study 349 
[32], but it was associated with a lesser P/AI in another study [31]. The previously mentioned 350 
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studies did not differentiate between cows that responded or did not respond to the Pre-GnRH 351 
treatment. Noncyclic cows that responded to pretreatm nt with CIDR before the Ovsynch have 352 
been reported to have greater P/AI than nonresponding cows [45].  In the current study, only 353 
41.2% of cows with a follicular cyst showed a luteal structure after a single Pre-GnRH treatment. 354 
This indicates that a single Pre-GnRH treatment maynot be enough to induce the desired effect 355 
of the Pre-GnRH treatment (i.e. induction of ovulation and formation of a luteal structure before 356 
the initiation of the Ovsynch).   357 
Inclusion of a New CIDR insert into the Ovsynch (i.e New-CIDR treatment regimen) tended 358 
to improve the P/AI 30 and P/AI 70 in the current study. Previous studies reported that the 359 
inclusion of CIDR inserts into the Ovsynch improved the P/AI in cows diagnosed with a 360 
persistent follicle but not in cows diagnosed with cystic ovarian disease [4, 10]. A previous study 361 
reported a P/AI percentage of 52% in cows with cysti  ovarian disease treated with a CIDR-362 
based ovulation-synchronization treatment [20], which is much higher than the P/AI percentage 363 
(34.86%) reported in the current study following the same treatment. The differences between 364 
studies could be attributed to differences in herd management plans and the cow’s genetic 365 
between herds. The addition of a single Pre-GnRH treatment before imposing the New-CIDR 366 
protocol (i.e. G-New CIDR treatment regimen) did not achieve significant improvement in the 367 
odds of pregnancy compared with the New-CIDR treatmnt regimen. 368 
Although the New-CIDR and the G-New CIDR treatment regimens achieved an important 369 
clinical improvement in the P/AI percentage compared with the Ovsynch treatment regimen, this 370 
effect did not reach statistical significance. This could have been occurred because of the smaller 371 
number of cows treated with the Ovsynch treatment rgimen in the current study with 372 
subsequence reduction in the study power to detect significance differences between groups (e.g. 373 
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the number of cows treated with New-CIDR treatment r gimen was 6 times as those treated with 374 
Ovsynch). Post-hoc sample size calculations for this given example of the Ovsynch and the 375 
New-CIDR treatment regimens identified that 183 cows per group are required to identify a 376 
difference in P/AI 30 of 13% at 5% significance level and 80% power. Of note that, the 377 
differences in the odds of pregnancy in cows treated with RG-Ovsynch, New-CIDR, and G-New 378 
CIDR treatment regimens were marginal, however, the diagnosis to insemination intervals in 379 
cows treated with the RG-Ovsynch treatment regimen (24.7 days) is about 14 and 10 days longer 380 
than that in cows treated with New-CIDR or G-New CIDR treatment regimens, respectively. 381 
Before deciding which treatment regimen could achieve better economic benefit, any additional 382 
improvement in P/AI associated with RG-Ovsynch treatment regimen should be weighed against 383 
the prolonged days open occurred in cows treated with this treatment regimen. Of note also that, 384 
the dose of Pre-GnRH treatment applied in the current study was that the same as that commonly 385 
used in ovulation-synchronization regimens, i.e. 100 µg. Using larger doses might minimize the 386 
number of required Pre-GnRH treatment doses and the uration from diagnosis till insemination 387 
in the RG-Ovsynch treatment regimen. 388 
The Reused-CIDR and the New-CIDR treatment regimens showed similar ability to induce 389 
cyst regression and ovulation at the end of these treatment regimens, but the odds of pregnancy 390 
in cows treated with the New-CIDR treatment regimen was as twice as that in those treated with 391 
the Reused-CIDR treatment regimen. The CIDR insert as a source of exogenous progesterone 392 
provides a mimicked physiological hormonal milieu for the growth and maturation of the 393 
synchronized follicular wave [25, 46]. Furthermore, it reduces the pulse frequency and the mean 394 
concentration of LH to a normal concentration and restores the ability of the hypothalamo-395 
pituitary axis to generate an LH surge in response to an increase in circulating estradiol [15-17]. 396 
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The required number of progesterone-releasing inserts is controversial. The inclusion of two 397 
CIDR inserts had improved the conception rate in cows that had no CL at the start of the CIDR-398 
Ovsynch treatment [46]. However, two other studies reported that using two or three 399 
progesterone-releasing inserts did not improve the P/AI compared with one treatment [47, 48]. In 400 
the current study, the new and the reused CIDR inserts induced similar serum progesterone 401 
concentration at 3 h, 3 days, and 7 days post insert on. It seems that the serum progesterone 402 
concentration induced by the reused CIDR insert was enough to restore the ability of the 403 
hypothalamo-pituitary axis to generate an LH surge and ovulation at the end of the treatment 404 
regimen. However, lower pregnancy probability in the Reused-CIDR treatment regimen raises a 405 
question of whether the very narrow non-significant difference in the serum progesterone 406 
concentration (about 0.27 ng/ml) observed after using of new and reused CIDR inserts could 407 
affect the fertilizing and the developmental ability of the oocytes in cows treated with Reused-408 
CIDR treatment regimen.  Further research is requird to investigate the underlying mechanism.  409 
A larger proportion of cows in the RG-Ovsynch and the G-New CIDR treatment regimens 410 
were found to have a CL or a luteal structure at the time of PGF2α administration. This 411 
observation is logical as in RG-Ovsynch treatment rgimen, the Ovsynch was not initiated until 412 
after detection of a luteal structure, and in the G-New CIDR treatment regimen the cows received 413 
2 doses of GnRH before the time of PGF2α administration. Cows developed or did not develop a 414 
luteal structure by the time of PGF2α administration showed similar P/AI percentages. This 415 
agrees with a previous study that reported that the luteal status at the time of PGF2α 416 
administration was not associated with the pregnancy probability in non-cyclic cows treated with 417 
a CIDR-based ovulation-synchronization treatment [33]. The presence of a CL at the time of 418 
PGF2α administration indicated an ovulation and the initiation of a new follicular wave in 419 
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response to the previous GnRH treatment/s. Cyclic cows that ovulate after the first GnRH 420 
treatment of the Ovsynch regimen have been reported to have higher P/AI than those that did not 421 
ovulate [49, 50]. The emergence of a synchronized follicular wave may occur without the 422 
development of a CL [44, 51]. In the current study, we did not monitor the emergence of new 423 
follicular waves after GnRH treatment, but the presence of a functional follicle at insemination 424 
and high ovulation rate (83 to 88%) at the end of the treatment regimens indicated that the 425 
emergence of a new follicular wave may have occurred without development of a CL in a large 426 
proportion of cows. This may explain why we could not detect differences in the pregnancy 427 
probability between cows that had or did not have a luteal structure at the time of PGF2α 428 
administration.  429 
We observed similar pregnancy probability in cows that retained or did not retain the 430 
follicular cyst up to the time of insemination. Our results are supported by a previous study that 431 
reported 70% ovulation and 36.7% conception rates in cows that had an ovarian cystic structure 432 
at the time of insemination [52]. In the current study, the pregnancy probability in cows ovulated 433 
with retention of the follicular cyst up to 8 to 10days post-insemination tended to be lower than 434 
that in cows ovulated with regression of the follicu ar cyst (P = 0.1). However, the pregnancy 435 
probability in cows ovulated in the presence of follicu ar cyst (30.4%) was still reasonable.  436 
5. Conclusions 437 
In comparison with Ovsynch, the application of weekly GnRH doses until detection of a 438 
luteal structure before initiating the Ovsynch (RG-Ovsynch) significantly improved the P/AI 30 439 
and 70 in cows diagnosed with follicular cysts. Furthe more, New-CIDR and G-New CIDR 440 
treatment regimens tended to improve the pregnancy probability on day 30 and 70 post-441 
insemination. The differences in the odds of pregnancy in cows treated with RG-Ovsynch, New-442 
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CIDR, and G-New CIDR treatment regimens were marginl a d any economic benefits achieved 443 
from this marginal increase in the P/AI should be int rpreted in light of prolonged diagnosis-to-444 
insemination interval occurred in the RG-Ovsynch compared with the New-CIDR and G-New 445 
CIDR treatment regimens. Overall, these three treatm n  regimens could have a positive impact 446 
on the fertility of the dairy herd investigated here as the P/AI in cows diagnosed with follicular 447 
cysts following these treatment regimens was comparable to that of cows inseminated after 448 
spontaneous estrus during the same period. The dominant ovarian structures identified at the time 449 
of PGF2α administration, or retention of the cyst up to the time of insemination, or 8 to10 days 450 
post-insemination were not associated with the P/AI.   451 
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Figure legend  609 
Fig. 1. A Schematic illustration of ovulation synchronizaton treatments used in the present 610 
study. GnRH = 100μg gonadorelin; PGF2α= 500 μg cloprostenol; FTAI= Fixed time artificial 611 
insemination; New-CIDR = insertion of a new controlled internal drug-release containing 1.38 g 612 
of progesterone during the shaded period; Reused-CIDR= insertion of a reused CIDR insert that 613 
was previously used for 7 days in another cow.  614 
Fig. 2. Results of ultrasonographic examination of follicular cystic cows treated with CIDR, G-615 
New CIDR, RG-Ovsynch or Reused-CIDR treatments. (A) Dominant ovarian structure at the 616 
time of CIDR removal or PG administration.  (B) proortion of cows with a follicular cyst at 617 
insemination (C) Dominant ovarian structures at days 8 to 10 post- insemination. The cows were 618 
classified as having either a follicular cyst [cows ith a follicular cyst without a luteal tissue], a 619 
follicle [cows with a follicular structure without a follicular cyst or a luteal structure], a CL 620 
[cows with a CL without a follicular cyst], a CL plus follicular cyst [cows with both a follicular 621 
cyst and a CL], or luteal cyst [cows with a luteal cyst]. Luteal structures collectively refer to 622 
cows that have a CL, a luteal cyst or a CL plus a follicular cyst. Follicular cyst collectively refers 623 
to cows that have a follicular cyst or a CL plus a follicular cyst. 624 
Fig. 3. Least square means of serum progesterone concentratio  at different time point in cows 625 
with severe ovarian inactivity that received a new or a reused CIDR inserts. Error bars indicate 626 
95% confidence intervals of the least square means. Different superscripts indicate differences 627 
between new and reused CIDR inserts within the same examination time point as well as 628 
differences between time points within the same insrt type (alpha = 0.05, Tukey-adjusted).  629 
  630 
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Table 1 631 
Examination time points and findings to be recorded uring ultrasongraphic examination of  632 
subgroup of cows submitted to RG-Ovsynch, New-CIDR and Reused-CIDR treatment protocols   633 
  634 
 At the time of PGF2α 
administration  




Number of cows  
 
238 179 256 
Finding to be 
recorded   
• Disappearance of cyst 
by this time  
• Appearance of luteal 
structure by this time 
(corpus luteum or cyst 
luteinization) 
•  Disappearance of 
cyst by this time  
 
• Disappearance of cyst 
by this time  
• Ovulation at the end of 
the treatment protocol 
based on appearance of 
corpus luteum that was 
not present at the time 




Table 2 635 
 Multivariable logistic regression model for variables associated with P/AI 30 and P/AI 70 in  636 
follicular cystic cows.  637 
 638 
Variables  Level P/AI n (%) OR 95% confidence 
interval of OR P-value 
P/AI 30 
DIM  
Less than 200 161/445 (36.2) Ref   
200-400 39/179 (21.8) 0.56 0.37, 0.86 0.01  





<65 58/150 (38.7) Ref   
≥65 to <70 76/185 (41.1) 1.04 0.66, 1.65 0.85   
≥70 to <75 39/160 (24.4) 0.49 0.29, 0.81 0.01  
≥ 75 41/169 (24.3) 0.48 0.29 - 0.78 0.01  
Treatments  
Ovsynch  8/38 (21.1) Ref   
New-CIDR  91/261 (34.9) 2.09 0.94, 5.16 0.09 
G-New CIDR 51/161 (31.7) 2.26 0.98, 5.73 0.07 
RG-Ovsynch  49/141 (34.7) 2.63 1.13, 6.72 0.03  
Reused CIDR 15/63 (23.8) 1.05 0.39, 2.94 0.93   
P/AI 70 
THI 
<65 51/150 (34.0) Ref   
≥65 to <70 65/185 (35.1) 1.01 0.64, 1.61 0.73    
≥70 to <75 34/160 (21.3) 0.46 0.27, 0.78 0.002 
≥ 75 37/169 (21.9) 0.46 0.27, 0.77 0.002  
Treatments 
Ovsynch  7/38 (18.4) Ref   
New-CIDR  78/261 (29.9) 2.01 0.87, 5.17 0.09 
G-New CIDR 47/161 (29.2) 2.19 0.93, 5.84 0.09  
RG-Ovsynch  43/141 (30.5) 2.49 1.04, 6.66 0.05 
Reused CIDR 12/63 (19.1) 0.96 0.34, 2.86 0.79    
 639 
OR = odds ratio; DIM = Days in milk; THI = Temperature humidity index; Ovsynch = GnRH 640 
injection at day 0 and 9, PGF2α administration at day 7 and insemination at day 10; New-CIDR = 641 
the same as Ovsynch with insertion of a new CIDR betwe n days 0 and 7; Reused-CIDR = the 642 
same as Ovsynch with insertion of reused CIDR betwen day 0 and 7, G-New CIDR = the same 643 
as New-CIDR with administration of Pre-GnRH 7 days before the start of the New-CIDR; RG-644 
Ovsynch = repeated weekly doses of Pre-GnRH  until a detection of a luteal structure upon 645 
ultrasonographic examination, at this point the Ovsynch was initiated.  646 
  647 
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Table 3 648 
 Dominant ovarian structure and cyst retention at each examination time points and its relation to 649 




Variable Descriptive statistics 
 
Relationship between dominant ovarian 
structure and the risk of P/AI 30* 
Level 




P-value 95% confidence 
interval of OR 
 On the 
beginning of 





CL  75 (53.2) 31 (41.3) Ref    
Luteal cyst  17(12.1) 7   (41.3) 0.96 0.94  0.31, 2.87 
CL+ Follicular 
cyst 
49(34.7) 11 (22.5) 0.46 0.07 0.19, 1.06 






structures   
Follicle  21 (8.8) 6 (28.6) Ref   
CL  42 (17.7) 17 (40.5) 1.70 0.38 0.52, 5.96 
Luteal cyst  33 (13.9) 8 (24.2) 0.82 0.76 0.23, 3.05 
Follicular cyst  66 (27.7) 20 (30.3) 1.06 0.92 0.36, .39 
CL + Follicular 
cyst  
76 (31.9) 25 (32.9) 1.286 0.67 0.42, 4.25 
Luteal 
structure# 
No 87 (36.6) 26(29.9) Ref   
yes 151 (63.4) 50 (33.1) 1.19 0.59   0.64, 2.25 
Follicular 
cyst¶    
No 96 (40.3) 31(32.3) Ref   
Yes 142 (59.7) 45 (31.7) 0.97 0.91 0.55, 1.75 
At day of 
insemination 
(179)  
Follicular cyst  No  83 (46.4) 24(28.9) Ref   
yes 96 (53.6) 25(26.1) 0.85 0.63   0.43, 1.67 






No  141 (55.1) 55(39.0) Ref   




CL  133 (52.0) 55 (41.4) Ref   
CL+ Follicular 
cyst 
92 (36.0) 28 (30.4) 0.61 0.1 0.34, 1.09 
*Calculated after adjustment for THI and treatment protocols  652 
**Applies only to the RG-Ovsynch 653 
*** 8 cows that were identified with a follicle and 23 cows identified only with a follicular cyst 654 
were excluded from the analysis as these resulted in complete separation in the model 655 
# Cows classified as having a luteal structure were identified either with a CL, a Luteal cyst or a 656 
CL plus a follicular cyst. Cows without a luteal structure were identified with a follicle or a 657 
follicular cyst.  658 
¶Cows with a follicular cyst included cows that had a follicular cyst or a CL plus a follicular 659 
cyst. Cows without a follicular cyst included cows that had a follicle or a CL as dominant 660 





- In follicular cyst, weekly GnRH until detection of CL before Ovsynch improved P/AI   
- New CIDR and G-New CIDR protocols tended improve the P/AI in follicular cystic cows 
- Reused CIDR inserts on days 0 to 7 of Ovsynch did not improve the P/AI  
-     P4 concentration up to 7 days post-insertion of new and reused-CIDR were similar  
 
